263. 脳腱黄色腫症 Cerebrotendinous xanthomatosis Clinical trials / Disease details

臨床試験数 : 5 / 薬物数 : 10 - (DrugBank : 2) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 4

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-205157	03/8/2020	13/02/2020	An open-label study of FPF1011 in patients with cerebrotendinous xanthomatosis (phase 3)	An open-label study of FPF1011 in patients with cerebrotendinous xanthomatosis (phase 3)	Cerebrotendinous xanthomatosis	Intervention name : FPF1011 INN of the intervention : Chenodeoxycholic acid Dosage And administration ...	Fujimoto Pharmaceutical Corporation	NULL	recruiting	0		BOTH	5	Phase 3	Japan
2	NCT04270682 (ClinicalTrials.gov)	January 31, 2020	12/2/2020	Study to Evaluate Patients With Cerebrotendinous Xanthomatosis	A Phase 3 Study to Evaluate the Effects of Chenodeoxycholic Acid in Adult and Pediatric Patients Wit ...	CTX	Drug: Blinded CDCA 250 mg TID;Drug: Placebo;Drug: Open-Label CDCA 250 mg TID;Drug: Rescue Medication ...	Travere Therapeutics, Inc.	NULL	Recruiting	1 Month	N/A	All	12	Phase 3	United States
3	NCT01613898 (ClinicalTrials.gov)	August 2010	22/5/2012	Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatos ...	Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatos ...	Cerebrotendinous Xanthomatosis (CTX)	Biological: Blood tests	Sheba Medical Center	NULL	Recruiting	10 Years	N/A	Both	17	N/A	Israel
4	NCT00018694 (ClinicalTrials.gov)	October 1999	3/7/2001	Cholestanol in Humans	Biologic Significance of Cholestanol in Man	Cerebrotendinous Xanthomatosis	Drug: Chenodeoxycholic Acid	Department of Veterans Affairs	NULL	Withdrawn	5 Years	80 Years	Both	0	N/A	United States
5	NCT00004346 (ClinicalTrials.gov)	January 1996	18/10/1999	Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for ...	Effects of Diet and Medication in Patients With Cerebrotendinous Xanthomatosis (CTX)	Cerebrotendinous Xanthomatosis	Drug: chenodeoxycholic acid;Drug: lovastatin	National Center for Research Resources (NCRR)	Oregon Health and Science University	Recruiting	N/A	N/A	Both	5	Phase 2	United States

First Previous1Next Last